Announces Resignation of Director

manufacturing & consulting

Pharmaceutical, Biotechnology & Medical Device Industries

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Clavis

Rank: President [?]

Points: 26378 [?]

Votes: 242 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Announces Resignation of Director

posted on Apr 14, 2009 02:53AM

April 13, 2009

PharmEng Announces Resignation of Director

TORONTO, ONTARIO--(Marketwire - April 13, 2009) - PharmEng International Inc. (the "Company") (TSX VENTURE:PII) today announced that effective immediately director Ravi Joshi has resigned from the board of directors of the Company and has also resigned from his position as Executive Vice-President of the Company.

The Company would like to sincerely thank Mr. Joshi for his service and dedication to the Company over the past years.

About PharmEng International Inc.

PharmEng International Inc., headquartered in Toronto, Canada, is a full-service consulting and contract manufacturing company that serves the pharmaceutical and biotechnology industries in North America and internationally. Consulting services include project management, engineering, GMP, validation, calibration, regulatory compliance and certified training. Contract manufacturing includes pharmaceutical support, formulation development, laboratory testing, and finished solid dosage and liquid products. PharmEng's shares trade on the TSX Venture Exchange under the symbol PII. For more information about PharmEng, please visit the Company's website at www.pharmeng.com.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply